Clinical Trial

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Study acronym: FFCD-2205
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational studies aimed at identifying new molecular, histological, circulating and radiological tumor biomarkers, potentially useful at every stage of diagnosis and prognostic or theranostic evaluation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-02; most recent amendment 2025-08-04.
Trial Details
NCT Number NCT06541652
Lead Sponsor Federation Francophone de Cancerologie Digestive
Collaborators: Société Nationale Française de Gastroentérologie
Conditions Hepatocholangiocarcinoma, Fibrolamellar Carcinoma, Hepatic Epithelioid Hemangioendothelioma, Hepatoblastoma, Hepatic Neuroendocrine Carcinoma, Hepatic Carcinosarcomas, Hepatic Cystadenoma, Hepatic Leiomyosarcomas +2 more
Enrollment 150 participants
Start Date 2024-03-26
Primary Completion 2026-02 (estimated)
Study Completion 2031-02 (estimated)
Updated on ClinicalTrials.gov 2025-08-05